Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 5Unknown 2Recruiting 2Enrolling by invitation 2Active not recruiting 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Weight Gain 1Recurrence 1Lymphoma, Large B-Cell, Diffuse 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × Weights and Measures × Clear all
NCT06288854 2024-11-21

Efficacy of Olanzapine on Weight Gain in Advanced Gynecologic Cancer with Paclitaxel and Carboplatin: a Double Blind, Placebo-controlled Randomized Trial

Department of Medical Services Ministry of Public Health of Thailand

Phase NA Unknown
48 enrolled

Weight Gain

NCT04113226 2023-02-08

Relyage

Centre Hospitalier Universitaire, Amiens

Phase 2 Unknown
114 enrolled
LymphoidSarcoma

Recurrence, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡